Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Attack on statin was completely unjustified

Your news item 'Row over Lancet alert on Crestor' (November 3) prompted me to read the original leading article.

The Lancet piece is an unjustified attack on an ethical pharmaceutical company, and was unprecedented in its viciousness. It accuses Sir Tom McKillop of being 'unprincipled' and implies AstraZeneca is withholding the truth from doctors and patients. I've looked, without success, for The Lancet's stinging criticism of Pfizer for having the temerity to market Lipitor on the basis of the CURVES data ­ a study very similar to AstraZeneca's maligned STELLAR study (not surprising since it was written by the same researcher) and no outcome data. Could someone help me out here with a reference?

Doctors should ignore The Lancet's claptrap and get on with prescribing the drugs for their patients that they think will help them most. I have been using Crestor in many of my patients and their total cholesterol and LDL cholesterol results at three months are the best I've seen.

The Lancet should know better. If I had a subscription I'd be writing to the editor to tell him I'd cancelled it. Thankfully, I don't.

Dr Sue Lipscombe

Brighton

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say